Výsledky vyhledávání - "Eva-Maria Pöllabauer"

Chapter 14: TBE-Prevention: Vaccines and Immunoglobulins

Autor: Eva-Maria Pöllabauer, Herwig Kollaritsch

Publikováno v: Tick-borne encephalitis - The Book.

Worldwide there are 6 different TBE vaccines – two from Western Europe, three from Russia and one from China. The two western European vaccines and one of the Russian vaccines have an adult and a pediatric formulation. The products names are FSME I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d4f2f7368278e18c766a16c0a646ea0
https://doi.org/10.33442/26613980_14-6

Zobrazit plný text záznamu

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines

Autor: Yvonne Beck, Alexandra Löw-Baselli, M. Keith Howard, Doris Kölch, Reinhard Ilk, Eva-Maria Pöllabauer, Stefan Kiermayr, Daniel Portsmouth, P. Noel Barrett, Richard Fritz, Klaus Orlinger, Thomas R. Kreil, Annett Hessel

Publikováno v: Journal of Virology

Studies evaluating the immunogenicity of two pediatric tick-borne encephalitis virus (TBEV) vaccines have reported contradictory results. These vaccines are based on two different strains of the European TBEV subtype: FSME-Immun Junior is based on th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7c78a0e1c1e0395917652cbf707ae2
https://doi.org/10.1128/jvi.02985-15

Zobrazit plný text záznamu

A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Autor: Brian A. Crowe, Roland Weisser, Herwig Kollaritsch, Peter G. Kremsner, Ian Livey, Markus Zeitlinger, Eva-Maria Pöllabauer, Tomas Jelinek, Daniel Portsmouth, Maria O'Rourke, Bernhard Schmitt, R. Aschoff, Thomas Dvorak, Gerald Aichinger, Meral Esen, Ingomar Naudts, P. Noel Barrett, Michael G. Schwendinger, Nina Wressnigg

Publikováno v: Clinical and Vaccine Immunology. 21:1490-1499

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection withBorrelia burgdorferisensu lato. There is limited information available about the use of OspA vaccines in this po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db7f668c922a548872d9eb03e6e9f677
https://doi.org/10.1128/cvi.00406-14

Zobrazit plný text záznamu

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population

Autor: Timo Vesikari, Otfried Kistner, Peter Richmond, Thomas Dvorak, Javier Díez-Domingo, Thomas R. Kreil, P. Noel Barrett, Eva Maria Pöllabauer, Bee Wah Lee, Hartmut J. Ehrlich, Sandor Fritsch, Richard Fritz, Maikel V. W. van der Velden, M. Keith Howard, Gerald Aichinger, Daniel Portsmouth

Publikováno v: Journal of Infectious Diseases. 209:12-23

BACKGROUND: Children are highly vulnerable to infection with novel influenza viruses. It is essential to develop candidate pandemic influenza vaccines that are safe and effective in the pediatric population. METHODS: Infants and children aged 6-35 mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b39699a373570e48cd7858bc93ece507
https://doi.org/10.1093/infdis/jit498

Zobrazit plný text záznamu

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Publikováno v: The Lancet Infectious Diseases. 13:680-689

Lyme borreliosis is caused by Borrelia burgdorferi sensu stricto in the USA and by several Borrelia species in Europe and Asia, but no human vaccine is available. We investigated the safety and immunogenicity of adjuvanted and non-adjuvanted vaccines

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519f5942da6b7ac025a96dc5a33b542b
https://doi.org/10.1016/s1473-3099(13)70110-5

Zobrazit plný text záznamu

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming

Autor: Alexandra Löw-Baselli, Karima Benamara, Gerald Aichinger, Sandor Fritsch, Herwig Kollaritsch, Maikel V. W. van der Velden, Markus Zeitlinger, Otfried Kistner, Markus Müller, Hartmut J. Ehrlich, Eva Maria Pöllabauer, Timo Vesikari, P. Noel Barrett

Publikováno v: Vaccine. 30:6127-6135

Background Influenza pandemic preparedness involves priming of the population with pre-pandemic vaccines. Such vaccines should be well tolerated and induce a long-lasting immunological memory that can effectively be boosted with a single dose of pand

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9592d1f048c9796213e132663f83f386
https://doi.org/10.1016/j.vaccine.2012.07.077

Zobrazit plný text záznamu

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior

Autor: Eva Maria Pöllabauer, Hartmut J. Ehrlich, Sandor Fritsch, Roman Prymula, Rudolf Angermayr, P. Noel Barrett, Alexander Geisberger, Alexandra Löw-Baselli, Borislava G. Pavlova

Publikováno v: Human Vaccines & Immunotherapeutics. 8:736-742

Tick-borne encephalitis (TBE) vaccination strategies to induce optimal seroprotection in children are under constant evaluation. This multi-center, randomized, controlled, phase III clinical study examined antibody persistence in children aged 1-11 y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccccfd4ce0a8ecb99ffb515cad99ce45
https://doi.org/10.4161/hv.20058

Zobrazit plný text záznamu

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants

Autor: Hartmut J. Ehrlich, Eva Maria Pöllabauer, Robert Petermann

Publikováno v: Vaccine. 27:1674-1679

Continuing additions of new vaccines to routine infant vaccination schedules have prompted concerns about potential interactions between vaccine components reducing desired protective effects. One hypothesis is that increasing loads of carrier protei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3b54dbf80408dbbc2cb46ae7947c4a
https://doi.org/10.1016/j.vaccine.2009.01.005

Zobrazit plný text záznamu

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine: A Meta-Analysis of Immunogenicity, Safety and Posology

Autor: Hartmut J. Ehrlich, Robert Petermann, Eva Maria Pöllabauer

Publikováno v: Human Vaccines. 1:131-139

A conjugate vaccine comprised of de-O-acetylated group C meningococcal polysaccharide coupled to tetanus toxoid (GCMP-TT) has been licensed in 32 countries and incorporated in a comprehensive UK vaccination program. Extensive evidence, forming the su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53a51802ecccb87a947f7070cb16494
https://doi.org/10.4161/hv.1.4.2018

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání